BioSpace News Archive

Business

AbbVie, REGENXBIO Partner on Potential One-Time Treatment for Wet AMD

The drug, called RGX-314, is a possible one-time treatment for wet AMD, diabetic retinopathy, and other chronic retinal diseases.

September 13, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

A Recurring COVID-19 Origin Theory and a Vaccine for Kids by Halloween?

Dr. Scott Gottlieb estimated that a vaccine for the 5-11-year-old age group could be available by Halloween – in a best-case scenario.

September 13, 2021
·
3 min read
·
Heather McKenzie
Deals

AzurRx Carves Out Slice of IBD Market in $229 Million Buyout

AzurRx will change its name to First Wave BioPharma, Inc., and the company’s shares will trade on the Nasdaq under the ticker symbol “FWBI.”

September 13, 2021
·
3 min read
·
Alex Keown
Deals

Five Life Sciences Companies Ramping up the Fall Flood of IPOs

Experts are predicting a record-breaking rush of IPOs this fall as companies flood to the Nasdaq.

September 13, 2021
·
3 min read
·
Kate Goodwin
Drug Development

Zynerba Pharmaceuticals Initiates RECONNECT, a Pivotal Phase 3 Trial of Zygel™ in Fragile X Syndrome

Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), today announces the initiation of a pivotal, multinational randomized, double-blind, placebo-controlled, multiple-center, efficacy and safety (RECONNECT) Phase 3 trial.

September 13, 2021
·
8 min read
Pharm Country

Amarin Announces First European Launch of VAZKEPA (icosapent ethyl) in Germany

Amarin Corporation plc (NASDAQ:AMRN) today announced the first European launch of VAZKEPA (icosapent ethyl) in Germany. VAZKEPA received marketing authorization from the European Commission in March 2021 and the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain in April 2021.

September 13, 2021
·
18 min read
Drug Development

Instil Bio Receives IND Clearance to Initiate a Phase 2 Clinical Trial for Patients with Advanced Melanoma

Instil Bio, Inc. today reported clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate DELTA-1

September 13, 2021
·
6 min read
FDA

FDA Grants Emergency Use Authorization for Visby Medical’s COVID-19 RT-PCR Test for Pooled Samples

Visby Medical™ announced today that its instrument-free Reverse Transcription (RT)-Polymerase Chain Reaction (PCR) COVID-19 test was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration

September 13, 2021
·
3 min read
Business

29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases

Abcam plc, a global leader in the supply of life science research tools, announces its interim results for the six- and 12-month periods ended 30 June 2021.

September 13, 2021
·
71 min read
Genetown

Syros to Present New Data from Phase 1 Clinical Trial of SY-5609 in Oral Presentation at ESMO Congress 2021

Management to Host Conference Call on Monday, September 20, 2021 at 4:00 p.m. ET

September 13, 2021
·
3 min read